- Home
- CLST vs RNTX Comparison
CLST vs RNTX Comparison
Compare CLST & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- RNTX
- Stock Information
- Founded
- CLST 1922
- RNTX 2001
- Country
- CLST United States
- RNTX United States
- Employees
- CLST N/A
- RNTX N/A
- Industry
- CLST
- RNTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- RNTX Health Care
- Exchange
- CLST Nasdaq
- RNTX Nasdaq
- Market Cap
- CLST 51.0M
- RNTX 44.2M
- IPO Year
- CLST N/A
- RNTX N/A
- Fundamental
- Price
- CLST $11.31
- RNTX $1.91
- Analyst Decision
- CLST
- RNTX
- Analyst Count
- CLST 0
- RNTX 0
- Target Price
- CLST N/A
- RNTX N/A
- AVG Volume (30 Days)
- CLST 6.4K
- RNTX 50.5K
- Earning Date
- CLST 05-01-2025
- RNTX 04-14-2025
- Dividend Yield
- CLST N/A
- RNTX N/A
- EPS Growth
- CLST N/A
- RNTX N/A
- EPS
- CLST N/A
- RNTX N/A
- Revenue
- CLST $5,174,000.00
- RNTX N/A
- Revenue This Year
- CLST N/A
- RNTX N/A
- Revenue Next Year
- CLST N/A
- RNTX N/A
- P/E Ratio
- CLST N/A
- RNTX N/A
- Revenue Growth
- CLST N/A
- RNTX N/A
- 52 Week Low
- CLST $10.78
- RNTX $1.61
- 52 Week High
- CLST $12.10
- RNTX $7.42
- Technical
- Relative Strength Index (RSI)
- CLST 27.40
- RNTX N/A
- Support Level
- CLST $11.62
- RNTX N/A
- Resistance Level
- CLST $11.78
- RNTX N/A
- Average True Range (ATR)
- CLST 0.12
- RNTX 0.00
- MACD
- CLST -0.03
- RNTX 0.00
- Stochastic Oscillator
- CLST 17.09
- RNTX 0.00
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a federally chartered community-oriented savings bank. The bank is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources which are used for the origination of loans. The Bank derives its income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.